$LEXX

$3.77 +$0.47 (14.24%) Close

$LEXX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 2.1M shares outstanding

Who owns LEXX?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 426.0%

BlackRock, Inc. 106.0% · Bunka Christopher 72.4%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

570

+72 vs last qtr

Net shares bought

+263.1K

by institutions in Q2 2026

New / sold out

143 / 71

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Price T Rowe Associates Inc /MD/ +328.2K
Vanguard Portfolio Management LLC +260.4K

Biggest sellers in Q2 2026

Maverick Capital LTD SOLD OUT −464.8K
UBS Group AG −172.9K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Lexaria Bioscience Corp in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+172.1%

+64.96% a year

Each share's claim on the business

−63.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.52M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years61% 3–5 years7% 1–3 years16% Under 1 year16%

Quarterly turnover

15.4%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting LEXX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	2.2M	106.00%	+85.8K (+4.0%)	≤2021	0.0%
Shares held by quarter Peak holding2.2M (Q2'26) Change over 8 quarters+1.0M Share of the company106.000% BlackRock, Inc.'s full portfolio →
VC Vanguard Capital Management LLC	893.2K	42.33%	+83.5K (+10.3%)	≤2021	0.0%
Shares held by quarter Peak holding893.2K (Q2'26) Change over 8 quarters+893.2K Share of the company42.330% Vanguard Capital Management LLC's full portfolio →

BlackRock, Inc.

2.2M

% of company

106.00%

Change vs last qtr

+85.8K (+4.0%)

Held since

≤2021

Vanguard Capital Management LLC

893.2K

% of company

42.33%

Change vs last qtr

+83.5K (+10.3%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Lexaria Bioscience Corp, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting LEXX on Form N-PORT; together they hold 363.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IC iShares Core S&P Small-Cap ETF iShares Trust	$671M	840.7K	39.85%	0.60%	June 30, 2026
FT First Trust RBA American Industrial Renaissance ETF First Trust Exchange-Traded Fund VI	$544M	680.7K	32.26%	4.73%	June 30, 2026

iShares Core S&P Small-Cap ETF

iShares Trust

Position value

$671M

% of company

39.85%

% of the fund

0.60%

As of

June 30, 2026

First Trust RBA American Industrial Renaissance ETF

First Trust Exchange-Traded Fund VI

Position value

$544M

% of company

32.26%

% of the fund

4.73%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Lexaria Bioscience Corp and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
BC Bunka Christopher Insider	1.5M	72.42%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company72.420% Bunka Christopher's insider activity →
DJ Docherty John Martin Insider	149.6K	7.09%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company7.090% Docherty John Martin's insider activity →

Bunka Christopher

Insider

1.5M

% of company

72.42%

Change vs last qtr

—

Held since

—

Docherty John Martin

Insider

149.6K

% of company

7.09%

Change vs last qtr

—

Held since

—

6 more holders behind a free account

See every insider and 5%+ holder of Lexaria Bioscience Corp.

Comments